Literature DB >> 33574611

Deep diversification of an AAV capsid protein by machine learning.

Drew H Bryant1, Ali Bashir1, Sam Sinai2,3,4,5, Nina K Jain2,3, Pierce J Ogden2,3,6, Patrick F Riley1, George M Church7,8, Lucy J Colwell9,10, Eric D Kelsic11,12,13.   

Abstract

Modern experimental technologies can assay large numbers of biological sequences, but engineered protein libraries rarely exceed the sequence diversity of natural protein families. Machine learning (ML) models trained directly on experimental data without biophysical modeling provide one route to accessing the full potential diversity of engineered proteins. Here we apply deep learning to design highly diverse adeno-associated virus 2 (AAV2) capsid protein variants that remain viable for packaging of a DNA payload. Focusing on a 28-amino acid segment, we generated 201,426 variants of the AAV2 wild-type (WT) sequence yielding 110,689 viable engineered capsids, 57,348 of which surpass the average diversity of natural AAV serotype sequences, with 12-29 mutations across this region. Even when trained on limited data, deep neural network models accurately predict capsid viability across diverse variants. This approach unlocks vast areas of functional but previously unreachable sequence space, with many potential applications for the generation of improved viral vectors and protein therapeutics.

Entities:  

Year:  2021        PMID: 33574611     DOI: 10.1038/s41587-020-00793-4

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  1 in total

Review 1.  Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors.

Authors:  Yu-Shan Tseng; Mavis Agbandje-McKenna
Journal:  Front Immunol       Date:  2014-01-30       Impact factor: 7.561

  1 in total
  21 in total

1.  Ultra-high-diversity factorizable libraries for efficient therapeutic discovery.

Authors:  Zheng Dai; Sachit D Saksena; Geraldine Horny; Christine Banholzer; Stefan Ewert; David K Gifford
Journal:  Genome Res       Date:  2022-06-23       Impact factor: 9.438

2.  Gene Therapy Approaches to Slow or Reverse Blindness From Inherited Retinal Degeneration: Growth Factors and Optogenetics.

Authors:  Russell N Van Gelder
Journal:  Int Ophthalmol Clin       Date:  2021-10-01

Review 3.  Viral Tools for Neural Circuit Tracing.

Authors:  Qing Liu; Yang Wu; Huadong Wang; Fan Jia; Fuqiang Xu
Journal:  Neurosci Bull       Date:  2022-09-22       Impact factor: 5.271

4.  Heterogeneity of the GFP fitness landscape and data-driven protein design.

Authors:  Louisa Gonzalez Somermeyer; Aubin Fleiss; Alexander S Mishin; Nina G Bozhanova; Anna A Igolkina; Jens Meiler; Maria-Elisenda Alaball Pujol; Ekaterina V Putintseva; Karen S Sarkisyan; Fyodor A Kondrashov
Journal:  Elife       Date:  2022-05-05       Impact factor: 8.713

Review 5.  Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders.

Authors:  Beverly L Davidson; Guangping Gao; Elizabeth Berry-Kravis; Allison M Bradbury; Carsten Bönnemann; Joseph D Buxbaum; Gavin R Corcoran; Steven J Gray; Heather Gray-Edwards; Robin J Kleiman; Adam J Shaywitz; Dan Wang; Huda Y Zoghbi; Terence R Flotte; Sitra Tauscher-Wisniewski; Cynthia J Tifft; Mustafa Sahin
Journal:  Mol Ther       Date:  2022-05-17       Impact factor: 12.910

6.  Relation Between the Number of Peaks and the Number of Reciprocal Sign Epistatic Interactions.

Authors:  Raimundo Saona; Fyodor A Kondrashov; Ksenia A Khudiakova
Journal:  Bull Math Biol       Date:  2022-06-17       Impact factor: 3.871

7.  On the sparsity of fitness functions and implications for learning.

Authors:  David H Brookes; Amirali Aghazadeh; Jennifer Listgarten
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-04       Impact factor: 12.779

Review 8.  Emerging therapeutic targets for cerebral edema.

Authors:  Ruchira M Jha; Sudhanshu P Raikwar; Sandra Mihaljevic; Amanda M Casabella; Joshua S Catapano; Anupama Rani; Shashvat Desai; Volodymyr Gerzanich; J Marc Simard
Journal:  Expert Opin Ther Targets       Date:  2022-01-02       Impact factor: 6.797

Review 9.  Machine learning to navigate fitness landscapes for protein engineering.

Authors:  Chase R Freschlin; Sarah A Fahlberg; Philip A Romero
Journal:  Curr Opin Biotechnol       Date:  2022-04-09       Impact factor: 10.279

10.  Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning.

Authors:  Anna Z Wec; Kathy S Lin; Jamie C Kwasnieski; Sam Sinai; Jeff Gerold; Eric D Kelsic
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.